Abstract
The cell-membrane folate receptor is a potential molecular target for tumor-selective drug delivery, including radiolabeled folate-chelate conjugates for diagnostic imaging. We review here some background on the folate receptor as tumor-associated molecular target for drug delivery, and briefly survey the literature on tumor-targeting with radiolabeled folate-chelate conjugates.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 811-817 |
| Number of pages | 7 |
| Journal | Nuclear Medicine and Biology |
| Volume | 30 |
| Issue number | 8 |
| DOIs | |
| State | Published - Nov 2003 |
| Externally published | Yes |
Keywords
- Folate binding protein
- Folate receptor
- Radionuclide imaging
- Radiopharmaceutical
- Tumor targeting
ASJC Scopus subject areas
- Molecular Medicine
- Radiology Nuclear Medicine and imaging
- Cancer Research
Fingerprint Dive into the research topics of 'The folate receptor as a molecular target for tumor-selective radionuclide delivery'. Together they form a unique fingerprint.
Cite this
Ke, C. Y., Mathias, C. J., & Green, M. A. (2003). The folate receptor as a molecular target for tumor-selective radionuclide delivery. Nuclear Medicine and Biology, 30(8), 811-817. https://doi.org/10.1016/S0969-8051(03)00117-3